Your browser doesn't support javascript.
loading
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma.
Scholler, Nathalie; Perbost, Regis; Locke, Frederick L; Jain, Michael D; Turcan, Sarah; Danan, Corinne; Chang, Edmund C; Neelapu, Sattva S; Miklos, David B; Jacobson, Caron A; Lekakis, Lazaros J; Lin, Yi; Ghobadi, Armin; Kim, Jenny J; Chou, Justin; Plaks, Vicki; Wang, Zixing; Xue, Allen; Mattie, Mike; Rossi, John M; Bot, Adrian; Galon, Jérôme.
Afiliación
  • Scholler N; Kite, a Gilead company, Santa Monica, CA, USA.
  • Perbost R; Gilead Sciences, Foster City, CA, USA.
  • Locke FL; Veracyte SAS, Marseille, France.
  • Jain MD; Moffitt Cancer Center, Tampa, FL, USA.
  • Turcan S; Moffitt Cancer Center, Tampa, FL, USA.
  • Danan C; Veracyte SAS, Marseille, France.
  • Chang EC; Veracyte SAS, Marseille, France.
  • Neelapu SS; Kite, a Gilead company, Santa Monica, CA, USA.
  • Miklos DB; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jacobson CA; Stanford University School of Medicine, Stanford, CA, USA.
  • Lekakis LJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lin Y; University of Miami Health System, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Ghobadi A; Mayo Clinic, Rochester, MN, USA.
  • Kim JJ; Washington University School of Medicine, St. Louis, MO, USA.
  • Chou J; Kite, a Gilead company, Santa Monica, CA, USA.
  • Plaks V; Kite, a Gilead company, Santa Monica, CA, USA.
  • Wang Z; Kite, a Gilead company, Santa Monica, CA, USA.
  • Xue A; Kite, a Gilead company, Santa Monica, CA, USA.
  • Mattie M; Kite, a Gilead company, Santa Monica, CA, USA.
  • Rossi JM; Kite, a Gilead company, Santa Monica, CA, USA.
  • Bot A; Kite, a Gilead company, Santa Monica, CA, USA.
  • Galon J; Kite, a Gilead company, Santa Monica, CA, USA.
Nat Med ; 28(9): 1872-1882, 2022 09.
Article en En | MEDLINE | ID: mdl-36038629

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Productos Biológicos / Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos